agilon health's third quarter revenue of $1.52B beats estimates while company raises 2026 EBITDA guidance

agilon health reported third quarter 2026 revenue of $1.52 billion, outperforming analyst expectations. The company achieved a swing to profitability with net income of $35 million, compared to a $110 million loss in the prior year. This turnaround was driven by significant improvements in medical expense ratios and disciplined contracting, prompting management to nearly double its full-year Adjusted EBITDA outlook.

Key Highlights

• Total revenue reached $1.52 billion, a 6% year-over-year increase supported by favorable burden of illness performance and payor pricing.
• The Medical Services Expense Ratio (MSER) improved dramatically to 88.5% from 104.0% in the prior year quarter, reflecting better medical cost management.
• Management raised full-year 2026 Adjusted EBITDA guidance to a range of $145 million to $155 million, up from the previous range of $75 million to $95 million.